Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
7.92
+0.47 (6.31%)
Sep 9, 2025, 4:00 PM - Market closed
Curanex Pharmaceuticals Market Cap
Curanex Pharmaceuticals has a market cap or net worth of $219.78 million as of September 10, 2025.
Market Cap
219.78M
Enterprise Value
220.15M
1-Year Change
n/a
Ranking
Category
Stock Price
7.92
Market Cap Chart
Since the IPO on August 26, 2025, Curanex Pharmaceuticals's market cap has increased from $111.00M to $219.78M, an increase of 98.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 219.78M | 6.31% |
| Sep 8, 2025 | 206.74M | 3.04% |
| Sep 5, 2025 | 200.63M | 1.83% |
| Sep 4, 2025 | 197.03M | 16.39% |
| Sep 3, 2025 | 169.28M | 4.10% |
| Sep 2, 2025 | 162.62M | 4.64% |
| Aug 29, 2025 | 155.40M | 7.90% |
| Aug 28, 2025 | 144.02M | 11.37% |
| Aug 27, 2025 | 129.32M | 16.50% |
| Aug 26, 2025 | 111.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |